BSE Live
Oct 29, 16:01Prev. Close
526.40
Open Price
532.00
Bid Price (Qty.)
531.00 (1)
Offer Price (Qty.)
535.00 (113)
NSE Live
Oct 29, 15:45Prev. Close
527.75
Open Price
528.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Lincoln Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 109.19 | 122.24 | 100.46 | 95.93 | 81.01 | |
| Net CashFlow From Operating Activities | 93.02 | 63.24 | 39.16 | 76.18 | 71.41 | |
| Net Cash Used In Investing Activities | -78.95 | -57.34 | -36.64 | -78.08 | -64.91 | |
| Net Cash Used From Financing Activities | -6.40 | -5.18 | -4.50 | -2.56 | -5.29 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 7.67 | 0.73 | -1.99 | -4.46 | 1.20 | |
| Cash And Cash Equivalents Begin of Year | 5.31 | 4.58 | 6.57 | 11.03 | 8.92 | |
| Cash And Cash Equivalents End Of Year | 12.97 | 5.31 | 4.58 | 6.57 | 10.13 |
07.08.2025
Lincoln Pharma Standalone June 2025 Net Sales at Rs 154.07 crore, up 4.61% Y-o-Y
24.06.2025
Lincoln Pharma Consolidated March 2025 Net Sales at Rs 168.18 crore, up 18.03% Y-o-Y
04.03.2025
Lincoln Pharma Consolidated December 2024 Net Sales at Rs 146.55 crore, up 0.07% Y-o-Y
28.11.2024
Lincoln Pharma Consolidated September 2024 Net Sales at Rs 161.21 crore, up 3.35% Y-o-Y
07.08.2025
Lincoln Pharma Standalone June 2025 Net Sales at Rs 154.07 crore, up 4.61% Y-o-Y
24.06.2025
Lincoln Pharma Consolidated March 2025 Net Sales at Rs 168.18 crore, up 18.03% Y-o-Y
04.03.2025
Lincoln Pharma Consolidated December 2024 Net Sales at Rs 146.55 crore, up 0.07% Y-o-Y
28.11.2024
Lincoln Pharma Consolidated September 2024 Net Sales at Rs 161.21 crore, up 3.35% Y-o-Y